#401 A Series of Unfortunate Events? Verisk Analytics v. AccuLynx and Lessons Learned
Verisk’s $2.35 billion acquisition of AccuLynx unexpectedly drew FTC scrutiny when Verisk, after announcing its […]
Verisk’s $2.35 billion acquisition of AccuLynx unexpectedly drew FTC scrutiny when Verisk, after announcing its […]
State-level pre-merger notification requirements are becoming more popular. But what is happening in California? Heather […]
The Federal 340B Drug Pricing Program has grown from a modest drug discount program into […]
What’s ahead for the ABA Antitrust Law Section in 2026–2027? Section Chair Melanie Aitken and […]
We are re-releasing this episode in tribute to Prof. Randy Picker, who passed away on […]
Several U.S. states have recently passed legislation aimed at AI pricing tools that use consumer […]
Competition law isn’t just for antitrust lawyers anymore—it’s increasingly a boardroom issue. What questions should […]
Vertical merger review has long rested on the principle that competitive harm is most likely […]
Are you as AI fluent as you should be? The American Bar Association’s “21 Days […]
Recently, the role of lobbying in M&A has become the talk of the antitrust bar […]
